Roger McCreary
Story Poster
Key Matchups: No. 14 Texas A&M vs. No. 13 Auburn
2 yr ago by Billy Liucci
No. 14 Texas A&M hosts No. 13 Auburn on Saturday afternoon as the Aggies look to beat the Tigers at Kyle Field for the first time ever. Ahead of the top-15 Southeastern Conference showdown in Aggieland, Billy Liucci details the in-game matchups to keep an eye on.
Story Poster
No. 14 Texas A&M vs. No. 13 Auburn: Players to Watch
2 yr ago by Olin Buchanan
Auburn rolls into Aggieland on Saturday for a top-15 SEC West showdown with Texas A&M, and Olin Buchanan identifies a handful of players to keep an eye on from both squads.
Story Poster
TexAgs All-SEC Team of the Week: Week 12
3 yr ago by Mike Huguenin
Alabama's DeVonta Smith put on a show again last weekend and freshman LSU QB Max Johnson led LSU to an upset of Florida in his first career start. They headline our All-SEC Team for Week 12.
Story Poster
No. 5 Texas A&M at Auburn: Players to Watch
3 yr ago by Olin Buchanan
Texas A&M will look to win their six consecutive football game when they hit the road for a date with the Auburn Tigers at Jordan-Hare Stadium. Ahead of Saturday's contest on The Plains, Olin Buchanan identifies a handful of players to keep an eye on this weekend.
Story Poster
TexAgs All-SEC team of the week: Week Five
3 yr ago by Mike Huguenin
It's hard to believe it, but the 2020 Southeastern Conference football season is nearly halfway done. Once again, Mike Huguenin, Olin Buchanan and Cole Cubelic selected the best of the best from around the league to create week five's All-SEC team of the week.
Story Poster
Agents of Chaos: Wild-card teams with the potential to tear up 2020’s script
3 yr ago by Andy Staples
College football seasons usually get weird, but in a season impacted mightily by a global pandemic, it's bound to get a heck of a lot weirder. The Athletic's Andy Staples and Max Olson look at a few teams that could spark some chaos this fall.
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.